| Landscape of genomic alterations in cervical carcinomas AI Ojesina, L Lichtenstein, SS Freeman, CS Pedamallu, ... Nature 506 (7488), 371-375, 2014 | 822 | 2014 |
| Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer SE Bojesen, KA Pooley, SE Johnatty, J Beesley, K Michailidou, JP Tyrer, ... Nature genetics 45 (4), 371-384, 2013 | 645 | 2013 |
| GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer PDP Pharoah, YY Tsai, SJ Ramus, CM Phelan, EL Goode, K Lawrenson, ... Nature genetics 45 (4), 362-370, 2013 | 415 | 2013 |
| The genomic landscape and evolution of endometrial carcinoma progression and abdominopelvic metastasis WJ Gibson, EA Hoivik, MK Halle, A Taylor-Weiner, AD Cherniack, A Berg, ... Nature genetics 48 (8), 848-855, 2016 | 196 | 2016 |
| Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer H Shen, BL Fridley, H Song, K Lawrenson, JM Cunningham, SJ Ramus, ... Nature communications 4 (1), 1628, 2013 | 178 | 2013 |
| Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21. 31 J Permuth-Wey, K Lawrenson, HC Shen, A Velkova, JP Tyrer, Z Chen, ... Nature communications 4 (1), 1627, 2013 | 136 | 2013 |
| Physical activity and lipoprotein metabolism: epidemiological evidence and clinical trials. A Berg, M Halle, I Franz, J Keul European journal of medical research 2 (6), 259-264, 1997 | 102 | 1997 |
| Loss of progesterone receptor links to high proliferation and increases from primary to metastatic endometrial cancer lesions IL Tangen, HMJ Werner, A Berg, MK Halle, K Kusonmano, J Trovik, ... European journal of cancer 50 (17), 3003-3010, 2014 | 91 | 2014 |
| Androgen receptor as potential therapeutic target in metastatic endometrial cancer IL Tangen, TB Onyango, R Kopperud, A Berg, MK Halle, AM Øyan, ... Oncotarget 7 (31), 49289, 2016 | 64 | 2016 |
| High level of HSF1 associates with aggressive endometrial carcinoma and suggests potential for HSP90 inhibitors H Engerud, IL Tangen, A Berg, K Kusonmano, MK Halle, AM Øyan, ... British journal of cancer 111 (1), 78-84, 2014 | 64 | 2014 |
| Molecular profiling of endometrial carcinoma precursor, primary and metastatic lesions suggests different targets for treatment in obese compared to non-obese patients A Berg, EA Hoivik, S Mjøs, F Holst, HMJ Werner, IL Tangen, ... Oncotarget 6 (2), 1327, 2015 | 63 | 2015 |
| Risk of Ovarian Cancer and the NF-κB Pathway: Genetic Association with IL1A and TNFSF10 B Charbonneau, MS Block, WR Bamlet, RA Vierkant, KR Kalli, Z Fogarty, ... Cancer research 74 (3), 852-861, 2014 | 61 | 2014 |
| HER2 expression patterns in paired primary and metastatic endometrial cancer lesions MK Halle, IL Tangen, HF Berg, EA Hoivik, KK Mauland, K Kusonmano, ... British journal of cancer 118 (3), 378-387, 2018 | 58 | 2018 |
| Stathmin protein level, a potential predictive marker for taxane treatment response in endometrial cancer HMJ Werner, J Trovik, MK Halle, E Wik, LA Akslen, E Birkeland, ... PLoS One 9 (2), e90141, 2014 | 52 | 2014 |
| Genome-wide association study identifies a possible susceptibility locus for endometrial cancer J Long, W Zheng, YB Xiang, F Lose, D Thompson, I Tomlinson, H Yu, ... Cancer epidemiology, biomarkers & prevention 21 (6), 980-987, 2012 | 48 | 2012 |
| Clinicopathologic and molecular markers in cervical carcinoma: a prospective cohort study MK Halle, AI Ojesina, H Engerud, K Woie, IL Tangen, F Holst, E Høivik, ... American journal of obstetrics and gynecology 217 (4), 432. e1-432. e17, 2017 | 45 | 2017 |
| ATAD2 overexpression links to enrichment of B-MYB-translational signatures and development of aggressive endometrial carcinoma C Krakstad, IL Tangen, EA Hoivik, MK Halle, A Berg, HM Werner, ... Oncotarget 6 (29), 28440, 2015 | 43 | 2015 |
| High degree of heterogeneity of PD-L1 and PD-1 from primary to metastatic endometrial cancer H Engerud, HF Berg, M Myrvold, MK Halle, L Bjorge, IS Haldorsen, ... Gynecologic oncology 157 (1), 260-267, 2020 | 42 | 2020 |
| Tissue and imaging biomarkers for hypoxia predict poor outcome in endometrial cancer A Berg, KE Fasmer, KK Mauland, S Ytre-Hauge, EA Hoivik, JA Husby, ... Oncotarget 7 (43), 69844, 2016 | 42 | 2016 |
| High-throughput mutation profiling of primary and metastatic endometrial cancers identifies KRAS, FGFR2 and PIK3CA to be frequently mutated C Krakstad, E Birkeland, D Seidel, K Kusonmano, K Petersen, S Mjøs, ... PloS one 7 (12), e52795, 2012 | 42 | 2012 |
Ingfrid Salvesen HaldorsenMohn Medical Imaging and Visualization Centre, Prof. at Univ of Bergen, Haukeland Univ. Hosp.Verified email at uib.no
